Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation
Sharma P, Boyers D, Boachie C, Stewart F, Miedzybrodzka Z, Simpson W, Kilonzo M, McNamee P, Mowatt G
Record ID 32011000778
English
Authors' recommendations:
Study found that comprehensive genetic analysis is the most effective test for detecting familial hypercholesterolaemia in terms of sensitivity and quality-adjusted life-year (QALY) gain, and is also highly cost-effective, with Elucigene FH20 and LIPOchip also cost-effective but at the expense of large QALY losses because of inferior sensitivity compared with comprehensive genetic analysis.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.hta.ac.uk/2450
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Hyperlipoproteinemia Type II
- Sequence Analysis, DNA
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2012 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.